Company overview
ProPharma Group is a leading global provider of regulatory, clinical, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies. They support products across the full lifecycle from early development through clinical trials, regulatory approval, and commercialization. Expertise spans therapeutic areas including oncology, cell and gene therapy, obesity, and infectious diseases, with technology-enabled solutions like the Prodigy platform.
Propharma Group is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include pharma consulting, regulatory services, clinical trials, pharmacovigilance, medtech compliance.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.propharmagroup.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- pharma consulting, regulatory services, clinical trials, pharmacovigilance, medtech compliance
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What services does ProPharma Group offer for pharma and MedTech?
- ProPharma provides regulatory consulting, clinical research solutions, pharmacovigilance, compliance, safety, technology, and operations services across the product lifecycle for pharmaceuticals, biotech, and medical devices.
- What therapeutic areas does ProPharma specialize in?
- Key areas include obesity & diabetes, oncology, cardiovascular, cell and gene therapy, CNS, and infectious diseases and vaccines.
- Does ProPharma support global regulatory and clinical needs?
- Yes, as a global provider, they offer clinical trial execution, regulatory consulting for medical devices and pharma, and support from concept through approval in multiple geographies.
Related editorial coverage
- Lilly buys 4E in non-opioid pain push: what investors should watch
- America's Innovation Engine: Small and Mid-Sized Biotechs Drive U.S. Clinical Trials, FDA Filings
- Friday Five: ASCO Takeaways, ADA Focus, China Deals & More – Clinical Trials
- FDA Extends Comment Period for Real-Time Clinical Trials Pilot, AI Use in Studies
- Uncertain FDA Leadership Raises Stakes in Clinical Trials: A Strategic Overview
- FDA's Shifting Tides: Navigating Clinical Trials Amidst Regulatory Uncertainty
Explore lab tools and QA/QC resources for R&D teams.
